Method and composition for reducing the effects of endogenous alkaline phosphatase
US5948630A · kind A · utility
5Cited by
9References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 5, 1996 |
| Grant date | Sep 7, 1999 |
| Priority date | — |
| Expiry date | Aug 5, 2016 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/581
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A composition and method are disclosed to reduce the effects that endogenous alkaline phosphatase found in some human bodily fluid samples have on solid phase immunoassay systems. The composition comprises a detergent, inhibitors to alkaline phosphatase, and a buffer and may contain a substrate to alkaline phosphatase.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.